Shree Ganesh [SGRL] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Shree Ganesh Remedies Ltd.

BSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Shree Ganesh Remedies Ltd. wins in 10 metrics, Gujarat Themis Biosyn Ltd. wins in 9 metrics, with 0 ties. Shree Ganesh Remedies Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Shree Ganesh Remedies Ltd. Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) 37.03 73.73 Shree Ganesh Remedies Ltd.
Price-to-Book Ratio 4.36 13.36 Shree Ganesh Remedies Ltd.
Debt-to-Equity Ratio 24.45 27.04 Shree Ganesh Remedies Ltd.
PEG Ratio -0.86 -17.55 Shree Ganesh Remedies Ltd.
EV/EBITDA 18.54 52.76 Shree Ganesh Remedies Ltd.
Profit Margin (TTM) 17.99% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) 19.25% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) 19.25% 40.16% Gujarat Themis Biosyn Ltd.
Return on Equity 15.89% 19.64% Gujarat Themis Biosyn Ltd.
Return on Assets (TTM) 12.02% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $74.69M $-251.22M Shree Ganesh Remedies Ltd.
Dividend Yield N/A 0.17% N/A
1-Year Return -2.45% 15.75% Gujarat Themis Biosyn Ltd.
Price-to-Sales Ratio (TTM) 6.66 22.23 Shree Ganesh Remedies Ltd.
Enterprise Value $6.74B $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 6.70 22.65 Shree Ganesh Remedies Ltd.
Gross Profit Margin (TTM) 70.00% 83.29% Gujarat Themis Biosyn Ltd.
Revenue per Share (TTM) $78 $15 Shree Ganesh Remedies Ltd.
Earnings per Share (Diluted) $14.09 $4.40 Shree Ganesh Remedies Ltd.
Beta (Stock Volatility) 0.19 -0.17 Gujarat Themis Biosyn Ltd.

Shree Ganesh Remedies Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

SGRL
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Shree Ganesh Remedies Ltd.-5.26%-12.23%-1.17%19.76%24.86%27.80%
Gujarat Themis Biosyn Ltd.-0.57%-4.89%4.00%38.98%-1.40%-12.59%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Shree Ganesh Remedies Ltd.-2.45%64.10%49.51%1,719.55%1,719.55%1,719.55%
Gujarat Themis Biosyn Ltd.15.75%76.92%76.92%76.92%76.92%76.92%

Performance & Financial Health Analysis: Shree Ganesh Remedies Ltd. vs Gujarat Themis Biosyn Ltd.

MetricSGRLGUJTHEM
Market Information
Market Cap i₹6.70B₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i4,48879,452
90 Day Avg. Volume i4,536106,446
Last Close₹568.85₹385.10
52 Week Range₹381.10 - ₹665.00₹225.05 - ₹479.00
% from 52W High-14.46%-19.60%
All-Time High₹950.05 (Jul 22, 2024)₹479.00 (Oct 27, 2025)
% from All-Time High-40.12%-19.60%
Growth Metrics
Quarterly Revenue Growth-0.22%0.10%
Quarterly Earnings Growth-0.43%-0.04%
Financial Health
Profit Margin (TTM) i0.18%0.30%
Operating Margin (TTM) i0.19%0.40%
Return on Equity (TTM) i0.16%0.20%
Debt to Equity (MRQ) i24.4527.04
Cash & Liquidity
Book Value per Share (MRQ)₹119.59₹24.29
Cash per Share (MRQ)₹26.25₹0.92
Operating Cash Flow (TTM) i₹337.14M₹970.68M
Levered Free Cash Flow (TTM) i₹230.68M₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend i₹0.00₹0.67

Valuation & Enterprise Metrics Analysis: Shree Ganesh Remedies Ltd. vs Gujarat Themis Biosyn Ltd.

MetricSGRL (Apr 24, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i37.0373.73
Forward P/E iN/AN/A
PEG Ratio i-0.86-17.55
Price to Sales (TTM) i6.6622.23
Price to Book (MRQ) i4.3613.36
Market Capitalization
Market Capitalization i₹6.70B₹35.41B
Enterprise Value i₹6.74B₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i6.7022.65
Enterprise to EBITDA i18.5452.76
Risk & Other Metrics
Beta i0.19-0.17
Book Value per Share (MRQ) i₹119.59₹24.29

Financial Statements Comparison: Shree Ganesh Remedies Ltd. vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSGRL (2025)GUJTHEM (2025)
Revenue/Sales i1.07B1.51B
Cost of Goods Sold i361.73M318.78M
COGS % of Revenue i34.0%21.1%
Gross Profit i703.31M1.19B
Gross Margin i66.0%78.9%
Research & Development i2.65M34.37M
Operating Income (EBIT) i301.91M642.49M
Operating Margin i28.3%42.6%
EBITDA i420.76M713.04M
EBITDA Margin i39.5%47.3%
Pre-Tax Income i312.68M655.38M
Pre-Tax Income % of Revenue i29.4%43.5%
Income Tax i81.99M167.66M
Income Tax % of Revenue i7.7%11.1%
Net Income (Profit) i230.68M487.72M
Profit Margin i21.7%32.3%

Balance Sheet & Liquidity Metrics

MetricSGRL (2025)GUJTHEM (2025)
Cash & Equivalents i99.43M116.94M
Total Current Assets i775.75M519.73M
Total Current Assets % of Revenue i72.8%34.5%
Total Current Liabilities i161.82M205.60M
Total Current Liabilities % of Revenue i15.2%13.6%
Long-Term Debt i296.08M296.36M
Long-Term Debt % of Revenue i27.8%19.7%
Total Shareholders Equity i1.45B2.48B
Retained Earnings i1.10B2.37B
Retained Earnings % of Revenue i103.1%157.4%
Property, Plant & Equipment i31.57M411.30M

Cash Flow Statement Comparison

MetricSGRL (2025)GUJTHEM (2025)
Operating Cash Flow i337.14M970.68M
Operating Cash Flow % of Revenue i31.7%64.4%
Capital Expenditures i-231.76M-1.16B
Free Cash Flow i74.69M-251.22M
FCF Margin i7.0%-16.7%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSGRLGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i12.84M108.97M
Float Shares i3.09M29.52M
% Held by Insiders i75.92%71.98%
% Held by Institutions i0.00%1.18%
% Held by Public i24.08%26.84%

Dividend Analysis & Yield Comparison: Shree Ganesh Remedies Ltd. vs Gujarat Themis Biosyn Ltd.

MetricSGRLGUJTHEM
Last 12-Month Dividend i₹0.00₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend i₹0.33₹0.22
3-Year Avg Dividend Yield i0.15%0.17%
3-Year Total Dividends i₹1.00₹0.67
Ex-Dividend DateSep 07, 2023Sep 04, 2025